CLINICAL_TRIALS
trial_result
· 2025-04-04
Clinical Trial Update: Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness [Phase 3]
Summary
A Phase 3 study evaluating tradipitant for motion sickness has completed, and results were posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Motion Sickness | Phase 3 | Status: COMPLETED | Results posted: 2025-04-04